XSpray Pharma AB (XSPRAY) — Capital Reinvestment Ratio

Latest as of September 2017: 138.93x

XSpray Pharma AB (XSPRAY) has a Capital Reinvestment Ratio of 138.93x as of September 2017, meaning it reinvests 139% of its operating cash flow (Skr46.00K) in capital expenditures (Skr6.39 Million). See XSpray Pharma AB net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

138.93x

Capex / Operating Cash Flow

Operating Cash Flow

Skr46.00K

SEK

Capital Expenditures

Skr6.39 Million

SEK

Data as of

Sep 2017

Most recent filing

Annual Capital Reinvestment Ratio for XSpray Pharma AB (None–None)

Year-by-year Capital Reinvestment Ratio for XSpray Pharma AB from None to None. For live market cap and broader valuation context, see XSpray Pharma AB market capitalisation.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow